 Sarah Sasse
Concepts (189)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Glucocorticoid | 11 | 2022 | 132 | 3.580 |
Why?
| | Dexamethasone | 9 | 2022 | 319 | 2.350 |
Why?
| | Kruppel-Like Transcription Factors | 4 | 2020 | 55 | 1.410 |
Why?
| | Muscle, Smooth | 3 | 2019 | 157 | 1.280 |
Why?
| | Glucocorticoids | 5 | 2022 | 545 | 1.180 |
Why?
| | NF-kappa B | 6 | 2022 | 664 | 1.120 |
Why?
| | Tumor Necrosis Factor-alpha | 5 | 2019 | 1159 | 1.040 |
Why?
| | Nuclear Proteins | 3 | 2017 | 594 | 0.910 |
Why?
| | Transcription, Genetic | 7 | 2021 | 1322 | 0.910 |
Why?
| | Anti-Inflammatory Agents | 2 | 2021 | 466 | 0.710 |
Why?
| | Gene Expression Regulation | 9 | 2022 | 2435 | 0.680 |
Why?
| | Proline Oxidase | 2 | 2015 | 3 | 0.650 |
Why?
| | Tumor Necrosis Factor alpha-Induced Protein 3 | 3 | 2016 | 7 | 0.640 |
Why?
| | Hyperoxia | 1 | 2019 | 97 | 0.640 |
Why?
| | Response Elements | 2 | 2015 | 82 | 0.620 |
Why?
| | Phospholipase C delta | 1 | 2017 | 2 | 0.620 |
Why?
| | Airway Remodeling | 1 | 2017 | 57 | 0.600 |
Why?
| | Airway Obstruction | 1 | 2019 | 167 | 0.600 |
Why?
| | Habituation, Psychophysiologic | 4 | 2011 | 56 | 0.600 |
Why?
| | Respiratory System | 2 | 2017 | 141 | 0.590 |
Why?
| | Saccharopine Dehydrogenases | 1 | 2015 | 2 | 0.540 |
Why?
| | RNA, Messenger | 5 | 2020 | 2657 | 0.520 |
Why?
| | Stress, Psychological | 7 | 2011 | 967 | 0.510 |
Why?
| | Inflammation | 4 | 2022 | 2545 | 0.500 |
Why?
| | Corticosterone | 5 | 2010 | 253 | 0.500 |
Why?
| | Adrenocorticotropic Hormone | 4 | 2010 | 152 | 0.440 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 194 | 0.440 |
Why?
| | Acoustic Stimulation | 5 | 2011 | 321 | 0.440 |
Why?
| | Transcription Factors | 3 | 2022 | 1567 | 0.390 |
Why?
| | Enhancer Elements, Genetic | 4 | 2021 | 151 | 0.380 |
Why?
| | Signal Transduction | 6 | 2021 | 4688 | 0.380 |
Why?
| | Idiopathic Pulmonary Fibrosis | 3 | 2022 | 451 | 0.370 |
Why?
| | DNA-Binding Proteins | 3 | 2014 | 1343 | 0.350 |
Why?
| | Cytokines | 2 | 2022 | 1880 | 0.350 |
Why?
| | Mucin-5B | 3 | 2022 | 175 | 0.350 |
Why?
| | Pituitary-Adrenal System | 5 | 2010 | 158 | 0.350 |
Why?
| | Hypothalamo-Hypophyseal System | 5 | 2010 | 194 | 0.340 |
Why?
| | Motor Activity | 3 | 2011 | 664 | 0.320 |
Why?
| | Genomics | 3 | 2022 | 668 | 0.310 |
Why?
| | Myocytes, Smooth Muscle | 2 | 2019 | 236 | 0.300 |
Why?
| | Chromatin Immunoprecipitation | 3 | 2017 | 134 | 0.300 |
Why?
| | Binding Sites | 4 | 2021 | 1221 | 0.280 |
Why?
| | Bronchi | 2 | 2018 | 241 | 0.270 |
Why?
| | Protein Binding | 5 | 2020 | 1969 | 0.260 |
Why?
| | Epithelial Cells | 4 | 2022 | 951 | 0.240 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2023 | 1130 | 0.240 |
Why?
| | RNA Polymerase II | 4 | 2021 | 282 | 0.220 |
Why?
| | Chromatin | 3 | 2022 | 439 | 0.210 |
Why?
| | Cells, Cultured | 4 | 2018 | 4044 | 0.210 |
Why?
| | Wood | 1 | 2021 | 20 | 0.200 |
Why?
| | Promoter Regions, Genetic | 3 | 2017 | 1157 | 0.200 |
Why?
| | Alveolar Epithelial Cells | 1 | 2022 | 101 | 0.200 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2021 | 36 | 0.200 |
Why?
| | Models, Genetic | 2 | 2021 | 592 | 0.200 |
Why?
| | Toll-Like Receptor 2 | 1 | 2022 | 127 | 0.200 |
Why?
| | Stress, Physiological | 3 | 2010 | 414 | 0.200 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2022 | 274 | 0.190 |
Why?
| | PPAR gamma | 1 | 2022 | 187 | 0.190 |
Why?
| | Particulate Matter | 1 | 2022 | 234 | 0.190 |
Why?
| | Animals | 13 | 2021 | 33152 | 0.190 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2023 | 2057 | 0.190 |
Why?
| | Smoke | 1 | 2021 | 137 | 0.180 |
Why?
| | Lung | 5 | 2022 | 3623 | 0.180 |
Why?
| | Humans | 19 | 2023 | 118251 | 0.180 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 219 | 0.180 |
Why?
| | Fluticasone | 1 | 2018 | 87 | 0.160 |
Why?
| | Cell Line | 4 | 2021 | 2693 | 0.160 |
Why?
| | Adrenergic beta-2 Receptor Agonists | 1 | 2018 | 32 | 0.160 |
Why?
| | Repressor Proteins | 1 | 2021 | 378 | 0.160 |
Why?
| | Drug Resistance | 1 | 2018 | 167 | 0.160 |
Why?
| | Cellular Senescence | 1 | 2019 | 151 | 0.160 |
Why?
| | Hypertrophy | 1 | 2017 | 121 | 0.150 |
Why?
| | Base Sequence | 3 | 2017 | 2148 | 0.150 |
Why?
| | HEK293 Cells | 1 | 2019 | 625 | 0.150 |
Why?
| | Transduction, Genetic | 1 | 2017 | 116 | 0.150 |
Why?
| | Transcriptional Activation | 2 | 2016 | 347 | 0.150 |
Why?
| | Primary Cell Culture | 1 | 2017 | 154 | 0.150 |
Why?
| | Trachea | 1 | 2018 | 225 | 0.140 |
Why?
| | Genes, Reporter | 1 | 2017 | 268 | 0.140 |
Why?
| | Adenoviridae | 1 | 2017 | 191 | 0.140 |
Why?
| | Asthma | 2 | 2022 | 2143 | 0.140 |
Why?
| | Respiratory Mucosa | 1 | 2018 | 252 | 0.140 |
Why?
| | Amygdala | 2 | 2009 | 175 | 0.140 |
Why?
| | Transcription Factor RelA | 1 | 2016 | 79 | 0.140 |
Why?
| | Gene Silencing | 1 | 2016 | 177 | 0.130 |
Why?
| | Rats, Sprague-Dawley | 6 | 2011 | 2434 | 0.130 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2015 | 75 | 0.130 |
Why?
| | Rats | 8 | 2011 | 5339 | 0.130 |
Why?
| | Interferon-gamma | 1 | 2018 | 735 | 0.130 |
Why?
| | Sequence Analysis, RNA | 1 | 2017 | 410 | 0.130 |
Why?
| | Adrenal Cortex Hormones | 1 | 2018 | 517 | 0.130 |
Why?
| | Transforming Growth Factor beta | 1 | 2017 | 461 | 0.120 |
Why?
| | Recombinant Fusion Proteins | 1 | 2017 | 650 | 0.120 |
Why?
| | Introns | 1 | 2014 | 233 | 0.110 |
Why?
| | Fatty Acid-Binding Proteins | 2 | 2023 | 62 | 0.110 |
Why?
| | Gene Regulatory Networks | 1 | 2014 | 238 | 0.110 |
Why?
| | Noise | 3 | 2011 | 67 | 0.110 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2015 | 449 | 0.110 |
Why?
| | Transcriptome | 1 | 2017 | 752 | 0.100 |
Why?
| | Physical Conditioning, Animal | 2 | 2011 | 204 | 0.100 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2014 | 403 | 0.100 |
Why?
| | A549 Cells | 2 | 2021 | 48 | 0.100 |
Why?
| | Fibroblasts | 1 | 2015 | 835 | 0.090 |
Why?
| | Nerve Growth Factors | 1 | 2010 | 74 | 0.090 |
Why?
| | Body Temperature | 1 | 2011 | 214 | 0.090 |
Why?
| | Mice | 3 | 2021 | 15446 | 0.090 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2855 | 0.090 |
Why?
| | Dentate Gyrus | 1 | 2010 | 32 | 0.090 |
Why?
| | Receptors, Adrenergic, alpha-1 | 1 | 2010 | 40 | 0.090 |
Why?
| | Escape Reaction | 1 | 2009 | 68 | 0.090 |
Why?
| | Olfactory Perception | 1 | 2009 | 21 | 0.090 |
Why?
| | Olfactory Pathways | 1 | 2009 | 56 | 0.090 |
Why?
| | Analysis of Variance | 5 | 2010 | 1288 | 0.080 |
Why?
| | Male | 10 | 2018 | 57474 | 0.080 |
Why?
| | Adrenal Glands | 1 | 2008 | 72 | 0.080 |
Why?
| | Infant, Newborn | 1 | 2019 | 5230 | 0.080 |
Why?
| | Organ Size | 1 | 2008 | 460 | 0.080 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 4 | 2010 | 817 | 0.080 |
Why?
| | Thymus Gland | 1 | 2008 | 298 | 0.080 |
Why?
| | Epigenesis, Genetic | 2 | 2022 | 536 | 0.080 |
Why?
| | Heart Rate | 1 | 2011 | 729 | 0.070 |
Why?
| | Mice, Knockout | 1 | 2013 | 2664 | 0.070 |
Why?
| | Radioimmunoassay | 3 | 2010 | 164 | 0.070 |
Why?
| | DNA Methylation | 2 | 2022 | 501 | 0.070 |
Why?
| | Gene Expression | 2 | 2022 | 1482 | 0.060 |
Why?
| | Neural Inhibition | 1 | 2005 | 160 | 0.060 |
Why?
| | Mice, Inbred C57BL | 1 | 2013 | 4887 | 0.060 |
Why?
| | Genetic Predisposition to Disease | 2 | 2022 | 2262 | 0.060 |
Why?
| | Transposases | 1 | 2022 | 9 | 0.060 |
Why?
| | Afghanistan | 1 | 2022 | 108 | 0.050 |
Why?
| | Cytochrome P-450 CYP1A1 | 1 | 2021 | 9 | 0.050 |
Why?
| | Budesonide | 1 | 2022 | 85 | 0.050 |
Why?
| | DNA (Cytosine-5-)-Methyltransferases | 1 | 2021 | 27 | 0.050 |
Why?
| | Cell Line, Transformed | 1 | 2021 | 135 | 0.050 |
Why?
| | NIH 3T3 Cells | 1 | 2021 | 138 | 0.050 |
Why?
| | Respiratory Tract Diseases | 1 | 2022 | 142 | 0.050 |
Why?
| | Gain of Function Mutation | 1 | 2021 | 30 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-ets | 1 | 2021 | 51 | 0.050 |
Why?
| | Young Adult | 1 | 2016 | 10731 | 0.050 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2021 | 93 | 0.050 |
Why?
| | Quantitative Trait Loci | 1 | 2022 | 324 | 0.050 |
Why?
| | Female | 3 | 2018 | 61261 | 0.050 |
Why?
| | Ferrets | 2 | 2009 | 21 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2022 | 504 | 0.040 |
Why?
| | STAT3 Transcription Factor | 1 | 2021 | 186 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 980 | 0.040 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2022 | 454 | 0.040 |
Why?
| | Odorants | 2 | 2009 | 137 | 0.040 |
Why?
| | Smell | 2 | 2009 | 118 | 0.040 |
Why?
| | Th1 Cells | 1 | 2018 | 132 | 0.040 |
Why?
| | Adolescent | 1 | 2016 | 18364 | 0.040 |
Why?
| | Hepatocyte Nuclear Factor 3-beta | 1 | 2017 | 10 | 0.040 |
Why?
| | Delayed-Action Preparations | 1 | 2018 | 161 | 0.040 |
Why?
| | Restraint, Physical | 2 | 2010 | 94 | 0.040 |
Why?
| | CpG Islands | 1 | 2017 | 119 | 0.040 |
Why?
| | In Situ Hybridization | 2 | 2010 | 303 | 0.040 |
Why?
| | Disease Progression | 1 | 2023 | 2477 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-fos | 2 | 2009 | 193 | 0.040 |
Why?
| | RNA | 1 | 2022 | 830 | 0.040 |
Why?
| | Gene Knockdown Techniques | 1 | 2017 | 312 | 0.030 |
Why?
| | Middle Aged | 1 | 2016 | 27510 | 0.030 |
Why?
| | DNA | 1 | 2022 | 1385 | 0.030 |
Why?
| | Macrophages | 1 | 2022 | 1311 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2017 | 562 | 0.030 |
Why?
| | RNA Interference | 1 | 2016 | 459 | 0.030 |
Why?
| | Behavior, Animal | 2 | 2009 | 486 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 1937 | 0.030 |
Why?
| | Blotting, Western | 1 | 2016 | 1186 | 0.030 |
Why?
| | Environment, Controlled | 1 | 2010 | 19 | 0.020 |
Why?
| | Risk Factors | 1 | 2023 | 8958 | 0.020 |
Why?
| | Zinc Sulfate | 1 | 2009 | 9 | 0.020 |
Why?
| | Vomeronasal Organ | 1 | 2009 | 10 | 0.020 |
Why?
| | Ibotenic Acid | 1 | 2009 | 6 | 0.020 |
Why?
| | Dominance-Subordination | 1 | 2009 | 16 | 0.020 |
Why?
| | Olfaction Disorders | 1 | 2009 | 47 | 0.020 |
Why?
| | Cell Count | 1 | 2009 | 315 | 0.020 |
Why?
| | Running | 1 | 2011 | 225 | 0.020 |
Why?
| | Amphetamine | 1 | 2005 | 23 | 0.020 |
Why?
| | Early Growth Response Protein 1 | 1 | 2005 | 32 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2009 | 1681 | 0.020 |
Why?
| | Paraventricular Hypothalamic Nucleus | 1 | 2005 | 36 | 0.020 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2005 | 129 | 0.020 |
Why?
| | Immediate-Early Proteins | 1 | 2005 | 54 | 0.020 |
Why?
| | Child, Preschool | 1 | 2018 | 9448 | 0.020 |
Why?
| | Central Nervous System Stimulants | 1 | 2005 | 142 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2010 | 3676 | 0.010 |
Why?
| | Child | 1 | 2018 | 19033 | 0.010 |
Why?
| | Time Factors | 1 | 2010 | 6368 | 0.010 |
Why?
| | Models, Biological | 1 | 2005 | 1701 | 0.010 |
Why?
|
|
Sasse's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|